https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5980731/
Abstract. Pain is a common symptom amongst patients with cancer. Adequate pain assessment and management is critical to improve the quality of life and health outcomes in this population. In this review we provide a framework for safely and effectively managing cancer-related pain by summarizing the evidence for the importance of controlling

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5969332/
Cancer pain management takes place in the context of multiple, sometimes competing personal goals. It is possible that technology could be used to help patients share individual symptom experiences and goals, thus enhancing tailored care. The challenge is for digital solutions to add value without adding undue burden.

https://spcare.bmj.com/content/8/2/204
Objectives Pain remains a problem for people with cancer despite effective treatments being available. We aimed to explore current pain management strategies used by patients, caregivers and professionals and to investigate opportunities for digital technologies to enhance cancer pain management. Methods A qualitative study comprising semistructured interviews and focus groups. Patients with

https://ascopubs.org/doi/10.1200/JCO.22.01357
As pain in patients and survivors of cancer is complex with different etiologies (eg, tumor burden, treatment-related, and non-cancer-related) and varying presentations (eg, neuropathic and musculoskeletal) and duration (eg, acute and chronic), pain management requires an interdisciplinary approach and should include both pharmacologic and nonpharmacologic treatments, where appropriate. 2

https://www.cancer.gov/news-events/cancer-currents-blog/2019/cancer-pain-new-approaches
The increased prevalence of cancer pain and the impact of the opioid epidemic on cancer pain management—and on managing chronic pain in general—have sparked renewed interest in developing new, ... To address those challenges, Dr. Somers is studying whether a shorter or lesser "dose" of a behavioral pain intervention can still provide

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9913127/
This could potentially lead to further undertreatment of cancer pain. On the other hand, the publication of new pain therapy guidelines may have improved the management of cancer pain [25,26,27]. Many new studies have been published on the prevalence of cancer pain since the 2016 systematic literature review of van den Beuken-van Everdingen et al.

https://www.tandfonline.com/doi/full/10.1586/14737140.7.11.1501
Cancer pain, chronic (so-called 'nonmalignant' pain) and acute pain are viewed as distinct clinical entities with somewhat unique treatment strategies. In fact, these 'distinct clinical entities' represent slightly different aspects of common pathophysiologic states, which blend together in a disease continuum.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10378332/
In a recent systematic review, including studies from 2014 to 2021, the overall prevalence of pain in cancer patients was 44% [ 2 ]. Moderate to severe pain was experienced by 31% of the patients (vs. 38% of the patients in a 2016 review). Pain prevalence in advanced metastatic and terminal cancer was 55% (vs. 66% in a 2016 review).

https://pubmed.ncbi.nlm.nih.gov/37504360/
This review focuses on the current utilization of opioids, the neuropathic pain component often neglected, and the techniques and non-pharmacological strategies available which help to personalize patient treatment. Cancer pain management is now closer to the management of chronic non-cancer pain, i.e., "an integrative and supportive pain care

https://www.cancer.gov/about-cancer/treatment/side-effects/pain/pain-hp-pdq
Also important is provider awareness of the patient's current pain management treatment plan and how the patient has responded to treatment; this includes how adequately the current treatment plan addresses any breakthrough or episodic pain. ... Measurement of cancer pain via patient self-report. In: Chapman CR, Foley KM, eds.: Current and

https://bmccancer.biomedcentral.com/articles/10.1186/s12885-024-12455-8
Background. Despite recent improvements in cancer detection and survival rates, managing cancer-related pain remains a significant challenge. Compared to neuropathic and inflammatory pain conditions, cancer pain mechanisms are poorly understood, despite pain being one of the most feared symptoms by cancer patients and significantly impairing their quality of life, daily activities, and social

https://www.annalsofoncology.org/article/S0923-7534(24)00017-6/fulltext
Pain is a constant companion across the cancer patient management pathway, right from diagnosis to the remission stage. Studies have shown that between 33% and 40% of cancer survivors have reported suffering from chronic pain, due to suboptimal pain management.1,2 We have read with great interest the recommendations laid out in the European Society of Medical Oncology (ESMO) clinical practice

https://www.thelancet.com/article/S0140-6736(11)60236-5/fulltext
In patients with active cancer, the management of chronic pain is an essential element in a comprehensive strategy for palliative care. This strategy emphasises multidimensional assessment and the coordinated use of treatments that together mitigate suffering and provide support to the patient and family. This review describes this framework, an approach to pain assessment, and widely accepted

https://education.nccn.org/node/89889
Current Clinical Challenges in Cancer Pain Management. Opioid abuse is an increasing concern in the US; drug poisoning remains the leading cause of injury-related death with the number of opioid overdose deaths increasing in recent years; however, in the context of this crisis, patient access to much-needed pain medication must be protected.

https://www.researchgate.net/publication/317242616_What_are_the_current_challenges_of_managing_cancer_pain_and_could_digital_technologies_help
Cancer pain has been well-recognized as one of the common complications suffered by patients with a range of cancers, occurring approximately 25% for the first time [20]. e incidence of pain in

https://pubmed.ncbi.nlm.nih.gov/18020918/
Current challenges in cancer pain management: does the WHO ladder approach still have relevance? Expert Rev Anticancer Ther. 2007 Nov;7 (11):1501-2. doi: 10.1586/14737140.7.11.1501.

https://www.onclive.com/view/challenges-and-breakthroughs-in-cancer-pain-management
Judith A. Paice, PhD, RN, FAAN. Cancer pain management has greatly improved with advances in oral and intravenous medication. However, several challenges still exist in administration.

https://www.ons.org/onf/50/3/barriers-nurses-providing-cancer-pain-management-qualitative-systematic-review
By 2060, it is estimated that more than 16 million individuals per year will die from malignant neoplasms and experience health-related distress (Armoogum et al., 2020). Cancer pain is one of the leading causes of health-related distress among patients with cancer and is a significant symptom of the disease and its treatment (Money & Garber, 2018).

https://pubmed.ncbi.nlm.nih.gov/28554888/
Grants and funding. Cancer pain management takes place in the context of multiple, sometimes competing personal goals. It is possible that technology could be used to help patients share individual symptom experiences and goals, thus enhancing tailored care. The challenge is for digital solutions to add value without a ….

https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(99)01310-0/fulltext
Patients with cancer have diverse symptoms, impairments in physical and psychological functioning, and other difficulties that can undermine their quality of life. If inadequately controlled, pain can have a profoundly adverse impact on the patient and his or her family. The critical importance of pain management as part of routine cancer care has been forcefully advanced by WHO

https://www.researchgate.net/publication/5826005_Current_challenges_in_cancer_pain_management_does_the_WHO_ladder_approach_still_have_relevance
Lastly, as cancer evolves into a chronic illness, with co-morbid conditions, recurrent cancer, and treatment toxicities from repeated antineoplastic therapies, pain management challenges in the

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10387299/
Introduction and background. According to the American Cancer Society (ACS), oncologic pain derived from cancer itself can vary according to a series of factors, including the type of cancer, the stage, pain tolerance of the patient, and concomitant conditions [].Other factors, including lifestyle choices, such as drinking coffee, have been linked to the suppression of carcinogenesis in breast

https://pubmed.ncbi.nlm.nih.gov/37812491/
Background: To inform the development of an intervention, it is essential to have a well-developed theoretical understanding of how an intervention causes change, as stated in the UK Medical Research Council guidelines for developing complex interventions. Theoretical foundations are often ignored in the development of mobile health apps intended to support pain self-management for patients

https://spcare.bmj.com/content/bmjspcare/8/2/204.full.pdf
Patients had personal goals which involved controlling pain intensity and balancing this with analgesic use, side effects, overall symptom burden and social/physical activities. Digital technologies were embraced by most patients, and made living life with advanced cancer easier and richer (eg, video calls with family).

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3605546/
Approximately one quarter of the world's population will develop cancer at some point in their lifetime. A high proportion will experience associated pain. 1, 2 Despite the World Health Organisation (WHO)'s assertion that over 80% of cancer pain is responsive to inexpensive oral medication, 3 research suggests it remains undertreated in both the developed and the developing world. 1 To

https://www.mdpi.com/2077-0383/13/12/3590
Background: Spinal cord compression is a formidable complication of advanced cancer, and clinicians of copious specialities often have to encounter significant complex challenges in terms of diagnosis, management, and prognosis. Metastatic lesions from cancer are a common cause of spinal cord compression, affecting a substantial portion of oncology patients, and only in the US has the

https://www.weforum.org/agenda/2024/06/cancer-treatment-and-diagnosis-breakthroughs/
England's National Health Service (NHS) is to be the first in the world to make use of a cancer treatment injection, which takes just seven minutes to administer, rather than the current time of up to an hour to have the same drug via intravenous infusion.This will not only speed up the treatment process for patients, but also free up time for medical professionals.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3229856/
Both acute and chronic pain has been well documented as one of the most frequent and distressing symptoms in cancer, and has been shown to adversely affect quality of life. 1-5 While it is difficult to be precise, it has been estimated that pain is present in 36-61% of patients depending on cancer type, stage of disease, and patient setting e.g. in-patient or out-patient. 1 Of those patients